Status:
COMPLETED
LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Garfield Memorial Fund
Conditions:
Safety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory mon...
Detailed Description
Many of the medications that clinicians prescribe to prevent or treat disease can result in unanticipated and unintended toxic effects. Many national clinical guidelines recommend baseline and periodi...
Eligibility Criteria
Inclusion
- Dispensed one of 12 drugs or classes of drugs where baseline safety laboratory monitoring is recommended and labs have not been completed 6 months prior or 5 days after the dispense of the medication.
- 18 years of age or older
- 12-month HMO membership
- drug benefit coverage
- has telephone number
Exclusion
- recommended baseline laboratory monitoring completed
- receives care and/or resides in hospice, nursing home, care outside HMO
- enrolled in other care management program
- nonEnglish speaking needing translation services
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00256386
Start Date
January 1 2004
End Date
March 1 2005
Last Update
November 30 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227